View Future GrowthBATM Advanced Communications 過去の業績過去 基準チェック /06BATM Advanced Communicationsの収益は年間平均-76.9%の割合で減少していますが、 Communications業界の収益は年間 減少しています。収益は年間0.9% 8.5%割合で 減少しています。主要情報-76.86%収益成長率-76.86%EPS成長率Communications 業界の成長31.77%収益成長率-8.51%株主資本利益率-19.89%ネット・マージン-9.89%前回の決算情報31 Dec 2025最近の業績更新お知らせ • Jul 24BATM Advanced Communications Ltd. to Report First Half, 2025 Results on Aug 18, 2025BATM Advanced Communications Ltd. announced that they will report first half, 2025 results on Aug 18, 2025お知らせ • Mar 05BATM Advanced Communications Ltd. to Report Fiscal Year 2024 Results on Mar 17, 2025BATM Advanced Communications Ltd. announced that they will report fiscal year 2024 results on Mar 17, 2025お知らせ • Feb 29BATM Advanced Communications Ltd. to Report Fiscal Year 2023 Results on Mar 12, 2024BATM Advanced Communications Ltd. announced that they will report fiscal year 2023 results on Mar 12, 2024すべての更新を表示Recent updatesお知らせ • Nov 06BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025. Location: the groups registered office, 4 ha harash street, nave ne eman industrial area, p o b 7318, 4524075 hod hasharon, Israelお知らせ • Oct 08Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million.DR.Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million on October 6, 2025. Under the terms of the Sale Agreement, the Group will sell AMS to Dr. Zvi Marom, a non-executive director and significant shareholder of the Group, in exchange for his entire shareholding of 96,794,500 ordinary shares of in BATM, representing c. 22.2% of the existing issued share capital. The transaction values AMS at £17.6m, based on the closing price of the Group's Ordinary Shares. Following completion, Dr. Marom will cease to be a shareholder of the Group and will resign as a director of the Group. The completion of the sale is subject to the approval of shareholders at a general meeting and and all other legal and regulatory requirements; the Board will issue a circular to convene this general meeting in due course. Mark Percy, Anita Ghanekar, James Thomas acted as advisor to BATM Advanced Communications.お知らせ • Sep 27BATM Advanced Communications Ltd. Announces Board and Committee ChangesBATM Advanced Communications Ltd. announced that Harel Locker is retiring from his position as an external director, as defined under Israeli law, of the Group with immediate effect. Mr. Locker completes his third three-year term as an external director of BATM. External directors under Israeli law are appointed for a minimum of one three-year term, which may be extended by the company (subject to shareholder approval) for no more than two additional terms of three years each. The Board will propose the appointment of a new external director for approval by shareholders at the Group's next annual general meeting. Following Mr. Locker's retirement from the Board, Prof. Varda Shalev, an external director of BATM, will assume the role of Interim Chair of the Audit Committee and a permanent chair will be appointed in due course.お知らせ • Jul 24BATM Advanced Communications Ltd. to Report First Half, 2025 Results on Aug 18, 2025BATM Advanced Communications Ltd. announced that they will report first half, 2025 results on Aug 18, 2025お知らせ • Jun 23+ 1 more updateBATM Advanced Communications Ltd. announces resignation of Ran Noy as Director, Effective 23 June 2025BATM Advanced Communications Ltd. announced that Ran Noy has resigned as Chief Financial Officer and a Director of the Group, effective 23 June 2025.お知らせ • Mar 05BATM Advanced Communications Ltd. to Report Fiscal Year 2024 Results on Mar 17, 2025BATM Advanced Communications Ltd. announced that they will report fiscal year 2024 results on Mar 17, 2025お知らせ • Dec 19BATM Approves the Appointment of Shmuel Ben Zvi as Non-Executive Director of the GroupBATM at its Annual General Meeting held on 19 December 2024, approved the appointment of Dr. Shmuel (Muli) Ben Zvi as a Non-executive Director of the Group with effect from the conclusion of the Meeting.お知らせ • Dec 12BATM Advanced Communications Limited Announces Commencement of Natslab Molecular Biology PlatformBATM Advanced Communications Limited announced that the NATlab molecular biology platform being developed by ADOR Diagnostics ("ADOR"), an associate company of the Group, has commenced pre-clinical validation at the Lazzaro Spallanzani National Institute for Infectious Diseases in Rome, Italy. This marks a key milestone in the development of NATlab and, the Group believes, will enable initial sales as well as increase industry awareness and interest from prospective partners. The advanced NATlab molecular biology platform is a point-of-care sample-to-answer solution designed to provide rapid and accurate diagnosis of infectious disease. It uses a patented isothermal amplification method for syndromic multiplex diagnostics to be able to rapidly identify a broad range of pathogens from a single test. The commencement of the pre-clinical validation phase follows the successful completion of pre-clinical trials, which were conducted at the Tzafom Medical Center in Israel, to confirm the validity of the biological process that ADOR has developed and that it can be performed within the NATlab cartridge and analyser device. NATlab identified all negative samples and had a 97% sensitivity for the positive samples, confirming the efficacy of the system and its ability to out-perform competing solutions available in the market because of its multiplex diagnostic capability for rapid and accurate diagnosis. ADOR has now made significant progress with NATlab with the full system entering the pre-clinical validation phase at the Lazzaro Sp allanzani National Institute forinfectious Diseases in Rome, a leading centre for infectious disease research and treatment. Successful completion of the pre-clinical validation is expected to enable initial sales of the NATlab and the commencement of the regulatory process under the European Union In Vitro Diagnostic Medical Device Regulation to become eligible for sale in the EU market. In addition, following the success of the pre-clinical trials, ADOR, in collaboration with the Tzafom Medical center, has received a grant from the Israel Innovation Authority to develop a NATlab panel for the diagnosis of stomach ulcers. The total value is NIS 3.4 million (c. $1 million), which is to be granted over two years based on the achievement of milestones.お知らせ • Nov 15BATM Advanced Communications Ltd., Annual General Meeting, Dec 19, 2024BATM Advanced Communications Ltd., Annual General Meeting, Dec 19, 2024. Location: the groups registered office, 4 ha harash street, nave ne eman industrial area, p o b 7318, 4524075 hod hasharon, Israelお知らせ • Aug 19BATM Advanced Communications Ltd. Provides Earnings Guidance for the Second Half of 2024BATM Advanced Communications Ltd. provided earnings guidance for the second half of 2024. For the period, the company expects increase in revenue.お知らせ • May 03BATM Advanced Communications Ltd. Selected for Tb Diagnostics ProgrammeBATM announce that the Group has been selected for aprestigious programme, that is receiving funding from the European Union, for the development of an advanced tuberculosis ("TB") diagnostics solution. The Group has also been awarded a grant of €0.5 million towards the initial 18 months of the programme with the potential for additional funding to be awarded thereafter for the next stage. The Group was selected by the National Research Council of Italy (Consiglio Nazionale delle Ricerche) ("CNR") under a competitive process involving many companies and after a lengthy and detailed verification phase to participate in the programme alongside one of CNR's research institutes, the Institute for System Analysis and Computer Science (Istituto di Analisi dei Sistemi ed Informatica) ("IASI"). The Group's participation reflects its strategy to advance the BATM diagnostics division through developing advanced molecular diagnostics solutions for substantial infectious disease markets, with the global diagnostics market for TB being worth over $2 billion. It is also demonstrative of the steps that the Group is taking to drive long-term sustainable growth through investing in constant innovation to maintain the diagnostics division's technological edge. The programme is for the development of a diagnostics system, based on the Rolling Circle Amplification ("RCA") method, for the rapid identification of TB and multi-drug resistant TB. This builds on the existing work of the BATM diagnostics division for the development of a rapid, RCA-based sample-to-answer diagnostic solution for TB and multi-drug resistant TB. The programme is receiving funding from the European Regional Development Fund via the Lazio Regional Operational Program of the Lazio regional government.お知らせ • Feb 29BATM Advanced Communications Ltd. to Report Fiscal Year 2023 Results on Mar 12, 2024BATM Advanced Communications Ltd. announced that they will report fiscal year 2023 results on Mar 12, 2024収支内訳BATM Advanced Communications の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:BVCL.F 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費31 Dec 25123-1234530 Sep 25121-1034530 Jun 25119-834531 Mar 25118-833531 Dec 24117-732530 Jun 24115331331 Mar 24116231431 Dec 23117132430 Sep 23121034630 Jun 23119034731 Mar 23117032731 Dec 22116030730 Sep 22121130830 Jun 22126329831 Mar 22133830931 Dec 211401431930 Sep 211591733930 Jun 2117820351031 Mar 2118115351031 Dec 2018410361030 Sep 20164733930 Jun 20145531731 Mar 20134429731 Dec 19123428730 Sep 19120328730 Jun 19118227731 Mar 19119127731 Dec 18120027730 Sep 18118127730 Jun 18116126831 Mar 18111126831 Dec 17107025830 Sep 17101-125830 Jun 1795-324831 Mar 1793-224831 Dec 1690-124830 Sep 1693-724730 Jun 1695-1324731 Mar 1696-1324731 Dec 1597-1324730 Sep 1599-924730 Jun 15100-5257質の高い収益: BVCL.Fは現在利益が出ていません。利益率の向上: BVCL.Fは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: BVCL.Fは利益が出ておらず、過去 5 年間で損失は年間76.9%の割合で増加しています。成長の加速: BVCL.Fの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: BVCL.Fは利益が出ていないため、過去 1 年間の収益成長をCommunications業界 ( 11.5% ) と比較することは困難です。株主資本利益率高いROE: BVCL.Fは現在利益が出ていないため、自己資本利益率 ( -19.89% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YTech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/25 12:41終値2026/02/25 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋BATM Advanced Communications Ltd. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関null nullCavendishSimon StrongPeel Hunt LLPAlasdair YoungShore Capital Group Ltd1 その他のアナリストを表示
お知らせ • Jul 24BATM Advanced Communications Ltd. to Report First Half, 2025 Results on Aug 18, 2025BATM Advanced Communications Ltd. announced that they will report first half, 2025 results on Aug 18, 2025
お知らせ • Mar 05BATM Advanced Communications Ltd. to Report Fiscal Year 2024 Results on Mar 17, 2025BATM Advanced Communications Ltd. announced that they will report fiscal year 2024 results on Mar 17, 2025
お知らせ • Feb 29BATM Advanced Communications Ltd. to Report Fiscal Year 2023 Results on Mar 12, 2024BATM Advanced Communications Ltd. announced that they will report fiscal year 2023 results on Mar 12, 2024
お知らせ • Nov 06BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025BATM Advanced Communications Ltd., Annual General Meeting, Dec 10, 2025. Location: the groups registered office, 4 ha harash street, nave ne eman industrial area, p o b 7318, 4524075 hod hasharon, Israel
お知らせ • Oct 08Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million.DR.Zvi Marom entered into an agreement to acquire A.M.S. 2000 Trading Impex S.r.l from BATM Advanced Communications Ltd. (LSE:BVC) for £17.6 million on October 6, 2025. Under the terms of the Sale Agreement, the Group will sell AMS to Dr. Zvi Marom, a non-executive director and significant shareholder of the Group, in exchange for his entire shareholding of 96,794,500 ordinary shares of in BATM, representing c. 22.2% of the existing issued share capital. The transaction values AMS at £17.6m, based on the closing price of the Group's Ordinary Shares. Following completion, Dr. Marom will cease to be a shareholder of the Group and will resign as a director of the Group. The completion of the sale is subject to the approval of shareholders at a general meeting and and all other legal and regulatory requirements; the Board will issue a circular to convene this general meeting in due course. Mark Percy, Anita Ghanekar, James Thomas acted as advisor to BATM Advanced Communications.
お知らせ • Sep 27BATM Advanced Communications Ltd. Announces Board and Committee ChangesBATM Advanced Communications Ltd. announced that Harel Locker is retiring from his position as an external director, as defined under Israeli law, of the Group with immediate effect. Mr. Locker completes his third three-year term as an external director of BATM. External directors under Israeli law are appointed for a minimum of one three-year term, which may be extended by the company (subject to shareholder approval) for no more than two additional terms of three years each. The Board will propose the appointment of a new external director for approval by shareholders at the Group's next annual general meeting. Following Mr. Locker's retirement from the Board, Prof. Varda Shalev, an external director of BATM, will assume the role of Interim Chair of the Audit Committee and a permanent chair will be appointed in due course.
お知らせ • Jul 24BATM Advanced Communications Ltd. to Report First Half, 2025 Results on Aug 18, 2025BATM Advanced Communications Ltd. announced that they will report first half, 2025 results on Aug 18, 2025
お知らせ • Jun 23+ 1 more updateBATM Advanced Communications Ltd. announces resignation of Ran Noy as Director, Effective 23 June 2025BATM Advanced Communications Ltd. announced that Ran Noy has resigned as Chief Financial Officer and a Director of the Group, effective 23 June 2025.
お知らせ • Mar 05BATM Advanced Communications Ltd. to Report Fiscal Year 2024 Results on Mar 17, 2025BATM Advanced Communications Ltd. announced that they will report fiscal year 2024 results on Mar 17, 2025
お知らせ • Dec 19BATM Approves the Appointment of Shmuel Ben Zvi as Non-Executive Director of the GroupBATM at its Annual General Meeting held on 19 December 2024, approved the appointment of Dr. Shmuel (Muli) Ben Zvi as a Non-executive Director of the Group with effect from the conclusion of the Meeting.
お知らせ • Dec 12BATM Advanced Communications Limited Announces Commencement of Natslab Molecular Biology PlatformBATM Advanced Communications Limited announced that the NATlab molecular biology platform being developed by ADOR Diagnostics ("ADOR"), an associate company of the Group, has commenced pre-clinical validation at the Lazzaro Spallanzani National Institute for Infectious Diseases in Rome, Italy. This marks a key milestone in the development of NATlab and, the Group believes, will enable initial sales as well as increase industry awareness and interest from prospective partners. The advanced NATlab molecular biology platform is a point-of-care sample-to-answer solution designed to provide rapid and accurate diagnosis of infectious disease. It uses a patented isothermal amplification method for syndromic multiplex diagnostics to be able to rapidly identify a broad range of pathogens from a single test. The commencement of the pre-clinical validation phase follows the successful completion of pre-clinical trials, which were conducted at the Tzafom Medical Center in Israel, to confirm the validity of the biological process that ADOR has developed and that it can be performed within the NATlab cartridge and analyser device. NATlab identified all negative samples and had a 97% sensitivity for the positive samples, confirming the efficacy of the system and its ability to out-perform competing solutions available in the market because of its multiplex diagnostic capability for rapid and accurate diagnosis. ADOR has now made significant progress with NATlab with the full system entering the pre-clinical validation phase at the Lazzaro Sp allanzani National Institute forinfectious Diseases in Rome, a leading centre for infectious disease research and treatment. Successful completion of the pre-clinical validation is expected to enable initial sales of the NATlab and the commencement of the regulatory process under the European Union In Vitro Diagnostic Medical Device Regulation to become eligible for sale in the EU market. In addition, following the success of the pre-clinical trials, ADOR, in collaboration with the Tzafom Medical center, has received a grant from the Israel Innovation Authority to develop a NATlab panel for the diagnosis of stomach ulcers. The total value is NIS 3.4 million (c. $1 million), which is to be granted over two years based on the achievement of milestones.
お知らせ • Nov 15BATM Advanced Communications Ltd., Annual General Meeting, Dec 19, 2024BATM Advanced Communications Ltd., Annual General Meeting, Dec 19, 2024. Location: the groups registered office, 4 ha harash street, nave ne eman industrial area, p o b 7318, 4524075 hod hasharon, Israel
お知らせ • Aug 19BATM Advanced Communications Ltd. Provides Earnings Guidance for the Second Half of 2024BATM Advanced Communications Ltd. provided earnings guidance for the second half of 2024. For the period, the company expects increase in revenue.
お知らせ • May 03BATM Advanced Communications Ltd. Selected for Tb Diagnostics ProgrammeBATM announce that the Group has been selected for aprestigious programme, that is receiving funding from the European Union, for the development of an advanced tuberculosis ("TB") diagnostics solution. The Group has also been awarded a grant of €0.5 million towards the initial 18 months of the programme with the potential for additional funding to be awarded thereafter for the next stage. The Group was selected by the National Research Council of Italy (Consiglio Nazionale delle Ricerche) ("CNR") under a competitive process involving many companies and after a lengthy and detailed verification phase to participate in the programme alongside one of CNR's research institutes, the Institute for System Analysis and Computer Science (Istituto di Analisi dei Sistemi ed Informatica) ("IASI"). The Group's participation reflects its strategy to advance the BATM diagnostics division through developing advanced molecular diagnostics solutions for substantial infectious disease markets, with the global diagnostics market for TB being worth over $2 billion. It is also demonstrative of the steps that the Group is taking to drive long-term sustainable growth through investing in constant innovation to maintain the diagnostics division's technological edge. The programme is for the development of a diagnostics system, based on the Rolling Circle Amplification ("RCA") method, for the rapid identification of TB and multi-drug resistant TB. This builds on the existing work of the BATM diagnostics division for the development of a rapid, RCA-based sample-to-answer diagnostic solution for TB and multi-drug resistant TB. The programme is receiving funding from the European Regional Development Fund via the Lazio Regional Operational Program of the Lazio regional government.
お知らせ • Feb 29BATM Advanced Communications Ltd. to Report Fiscal Year 2023 Results on Mar 12, 2024BATM Advanced Communications Ltd. announced that they will report fiscal year 2023 results on Mar 12, 2024